98%
921
2 minutes
20
Background: Although electronic prescription cancellation such as via CancelRx can facilitate critical communication between prescribers and pharmacy staff about discontinued medications, there is little work that explores whether CancelRx meets the needs of pharmacy staff users.
Objective: This study leverages qualitative interviews with pharmacy staff to address the following question:
Methods: We conducted an inductive thematic analysis of interviews with 11 pharmacy staff members (pharmacists and pharmacy technicians) across three outpatient community pharmacy sites within an academic health care system.
Results: Three information needs themes were consistently identified by both pharmacists and pharmacy technicians: prescriber intent when initiating the CancelRx, clinical rationale for the medication change, and intended medication regimen. Notably, both pharmacists and pharmacy technicians often reported seeking multiple information needs not fully addressed by CancelRx in the electronic health record (EHR) to achieve the shared goals of correct dispensing of medications and supporting patient self-management.
Conclusions: Our qualitative analysis reveals that outpatient community pharmacy staff in an academic health care system often seek additional information from the (EHR) following medication changes communicated by CancelRx to meet their information needs. Ideally, the prescriber would provide sufficient information through CancelRx to automatically identify all discontinued prescriptions. These limitations highlight the need for design features that support routine communication of needed information at the time of a medication change, such as structured data elements.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10776446 | PMC |
http://dx.doi.org/10.1016/j.rcsop.2023.100398 | DOI Listing |
Am J Pharm Educ
September 2025
Touro College of Pharmacy, New York, NY.
Cancer rates are on the rise and new treatments are helping people live longer with cancer, yet the questions remains: when does one consider themselves a cancer survivor and what direction does one's career need to take when diagnosed with cancer? This commentary explores how mentoring can support working individuals, such as pharmacy faculty and staff, across the three distinct phases of cancer survivorship, (1) the acute phase including testing, diagnosis, staging, and treatment; (2) the post-treatment survival phase; and (3) the permanent phase of disease-free survival. While career mentoring programs may exist for pharmacy faculty and staff across various pharmacy practice settings, there is a notable lack of structured mentoring programs available for those faculty and staff navigating a cancer diagnosis, especially as mentoring needs shift throughout these three cancer survivorship phases. Thoughtful mentoring and support can significantly enhance the personal and professional quality of life for individuals with cancer.
View Article and Find Full Text PDFAnn Pharm Fr
September 2025
Pharmacie des Dispositifs Médicaux, CHU de Saint-Étienne, France.
Objectives: The objective of this work is to provide comprehensive training on the workflow of sterile medical devices (SMDs) in the operating room (OR) with the help of an exhaustive booklet and the introduction of an evaluation to assess OR nurses and hospital pharmacy technicians knowledge.
Methods: Each section of the booklet was written based on internal quality documents related to the SMD workflow at our hospital and was institutionally validated. A multiple-choice questionnaire based on the booklet was developed.
Int J Occup Saf Ergon
September 2025
Faculty of Sciences, Ain Shams University, Egypt.
Laboratory safety is a critical priority in educational institutions, particularly in microbiology laboratories where infectious disease diagnosis requires strict protocols. Contaminated personnel can unknowingly transmit pathogens beyond the laboratory, posing public health risks. This study explores strategies to enhance safety in a microbiology laboratory at an Egyptian university.
View Article and Find Full Text PDFJ Viral Hepat
October 2025
Clinical and Health Sciences, University of South Australia, Adelaide, South Australia, Australia.
Direct-acting antivirals (DAAs) have transformed hepatitis C virus (HCV) treatment in Australia since their inclusion on the Pharmaceutical Benefits Scheme (PBS) in 2016. Treatment has shifted from genotype-specific to pan-genotypic regimens, with glecaprevir/pibrentasvir and sofosbuvir/velpatasvir now recommended in clinical guidelines. This study examined trends in DAA dispensing in light of evolving treatment regimens.
View Article and Find Full Text PDFSubst Use Addctn J
October 2025
Program in Addiction Medicine, Yale School of Medicine, New Haven, CT, USA.
Background: Substance use is a major global public health challenge. A well-trained health care workforce is needed to prevent, address, and treat substance use disorders (SUD) internationally.
Methods: In September 2021, the Yale Schools of Medicine (YSM) and Public Health (YSPH) and the University of Jordan (UJ) collaborated to establish the Yale-UJ Joint Training Program in Addiction Medicine.